Admedus
August 16, 2018: In The Know
August 15, 2018 | Tags: 3M, Admedus, ANI Pharmaceuticals, Bind, Bright Health, Celcuity, Electromed, Mayo Clinic, Medtronic, OneOme, Rebiotix, Stella, Takeda, TE Connectivity, University of Minnesota
Mayo Clinic names Farrugia as new CEO
University of Minnesota reports breakthrough in 3-D printing for spinal cord repair
Takeda is banking on a SuperTarget-sized biologic plant in Brooklyn Park
Medtronic launches In.Pact Admiral drug-coated balloon in Japan
Mayo Clinic again ranked nation’s top hospital
How Pharmacogenomics Is Improving American Healthcare
This startup is daring to bring on-demand services to health insurance
Dambisa Moyo, Mildstorm CEO, elected to 3M board
Ancor Capital Partners Sells WellSpring Pharma Services, Inc.
Celcuity Reports Second Quarter 2018 Financial Results
Admedus extends successful distribution deal for medication delivery pumps
Fusionetics Closes Capital Investment from Stella
TE Connectivity beats the Street on Q3 results
The Microbiome Therapeutics Innovation Group Announces Coalition Formation and Leadership Team
May 17, 2018: In The Know
May 16, 2018 | Tags: Admedus, Aldevron, Be The Match, Biothera Pharmaceuticals, Blue Cross and Blue Shield of Minnesota, Boston Scientific, Coloplast, Ecolab, Electromed, Mayo Clinic, Medtronic, RxFunction, Sanofi, Sun BioPharma, University of Minnesota, Vyriad
Ecolab Ranks Eighth on 2018 Best Corporate Citizens List
Why Medtronic’s CEO Wants to Bring Values-Based Healthcare to Everyone
Boston Scientific’s drug-coated balloon succeeds in femoropopliteal segment at one year
U of M Honored as One the World’s Best at Spinning Off Companies from Research
Coloplast Announces the Launch of Biatain® Silicone with 3DFit Technology™
Blue Cross and Blue Shield of Minnesota Releases 2017 Community Report
Successful Commercialization of Gut Microbe Strain Could Net Mayo $55M
Minnesota med-tech industry seeks China tariff relief
Vyriad to build $9 million facility on former IBM site
Research Brief: UMN researchers make key discovery about human cancer virus protein
Women in Business Awards 2018: Kathleen Skarvan
Q&A With Chris McClain, VP of New Business Development and Sales
Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer
walkasins Tested for Longer-Term Effectiveness in Peripheral Neuropathy
Aldevron Names Marc Wolff Chief Financial Officer
Sun BioPharma Provides Business Update and Files Report for Q1 2018
Admedus using capital raised to advance product development and share price growth
May 3, 2018: In The Know
May 2, 2018 | Tags: 3M, Admedus, Ambient Clinical, ANI Pharmaceuticals, Cardionomic, DSI, Electromed, Mayo Clinic, Medibio, Medtronic, Microoptx, Minnetronix, Osprey Medical, Summit Medical, University of Minnesota
Entrepreneur of the Year Heartland Finalists Revealed, Minnesota Dominates Again
Cardionomic Nears Close of $9.6M Series B
Minne Ties® Agile MMF by Summit Medical Named Finalist for Medical Design Excellence Award
Ambient Clinical Analytics Solutions Proves Crucial in Saving Life
Medtronic Announces TiONIC(TM) Technology, a Titanium 3D Printed Platform for Spine Surgery Implants
Osprey Medical posts double-digit sales growth for DyeVert Plus system
Minnetronix Announces Appointment of Elissa Lindsoe as Chief Financial Officer
Medibio Announces Global Launch of Corporate Mental Health For Business
Admedus appoints medtech expert Michael Oswell as vice president, development
UMN faculty member appointed to new federal pain management task force
September 28, 2017: In the Know
September 28, 2017 | Tags: 3M, Abbott, Admedus, Boston Scientific, DoseMe, Mayo, Teva
- How Can Digital Health Alleviate Common Healthcare Pain Points?
- Post-Maria, Med-Tech Firms in Puerto Rico Work to Track Down Workers
- US Department of Defense Awards Humanetics Corporation $3.8 Million Grant for Advanced Development of Radiation Drug
- DoseMe Wins Place in Inaugural ANDHealth+ Program
- HealthLink Europe & International Acquired by Base Logistics Group
- Teva’s Migraine Candidate Shows Promising Late-Stage Data
- Boston Scientific Touts 3-year Alair Follow-up Study Results
- 3M Establishes a Global Relief Fund to Help Communities Affected by Recent Natural Disasters
- Inspire Medical Systems’ Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment
- Metavention CEO hops to another VC-backed startup
- Admedus CEO Ready To Transform Company Again With TAVR
- Abbott Labs gets FDA approval for MRI-friendly defibrillator
- Mayo Research into Microbiome-Nutrition Connection Lands ADM’s Backing
September 6, 2017: In the Know
September 6, 2017 | Tags: Admedus, Electromed, Mayo, Osprey Medical, VigiLanz
- Study Concludes Vagal Nerve Blocking Therapy is Cost-Effective
- A Seat at the Table: Healthcare Tech Leaders Form Unique Board
- Mayo Clinic Researchers Review the Clinical Potential of Senolytic Drugs on Aging
- Electromed, Inc. Announces Fiscal 2017 Fourth Quarter Financial Results
- Here are the Startups in gener8tor’s First Minnesota Accelerator
- Admedus eyes new revenue stream through supply agreement with 4C Medical Technologies
- VigiLanz Achieves Top Rating for Overall Satisfaction in KLAS AMS Performance Report
- Local Study May Keep More Hearts Beating
- Osprey Medical Bags $10.3M as Sales Gain Momentum
